ARVN
ARVN
NASDAQ · Pharmaceuticals

Arvinas Inc

$8.75
+0.07 (+0.81%)
As of Aug 8, 1:46 AM ET ·
Analyst Consensus
Buy
24
Analysts
High
Coverage
Buy 15 63%
Hold 8 33%
Sell 1 4%
Price Target
Analyst Price Target +656.8% upside
Low Target $44.47
Average Target $66.22
High Target $75.30
Current Price $8.75
Current
$8.75
Target
$66.22
$44.47 $66.22 avg $75.30
Scenario Analysis
Bear Case
$44.47
408.2%
Low target
Base Case
$66.22
+656.8%
Avg target
Bull Case
$75.30
+760.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$14.51
-39.7% from high
52-Week Low
$6.06
+44.4% from low
Target vs 52W High
$66.22
+356.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%